Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells-Reference-Cited by-同舟云学术

Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells

Published:2017-05-08 Issue:36 Volume:8 Page:60109-60122
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bagnato Paola¹,Castagnino Alessia¹,Cortese Katia¹,Bono Maria¹,Grasso Silvia²,Bellese Grazia¹,Daniele Tiziana³,Lundmark Richard⁴,Defilippi Paola²,Castagnola Patrizio⁵,Tacchetti Carlo¹³

Affiliation:

1. DIMES, Dipartimento di Medicina Sperimentale, Anatomia Umana, Università di Genova, Genova, Italy

2. Molecular Biotechnology Centre and Department of Genetics, Biology and Biochemistry, Torino, Italy

3. San Raffaele Scientific Institute, Experimental Imaging Centre, Milan, Italy

4. Department of Medical Biochemistry and Biophysics, Umea University, Umea, Sweden

5. Department of Integrated Oncological Therapies, IRCCS AOU - San Martino - IST, Largo Rosanna Benzi, Genova, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer;International Journal of Molecular Sciences;2024-08-08

2. Highly Multiplexing, Throughput and Efficient Single‐Cell Protein Analysis with Digital Microfluidics;Small Methods;2024-04-12

3. GTPase-activating protein ARAP1 regulates circular dorsal ruffles as a nutrient uptake mechanism in the Hep3B hepatocellular carcinoma cell line;2024-01-02

4. Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells;Biochemical Pharmacology;2023-07

5. A Novel Mechanism Underlying the Inhibitory Effects of Trastuzumab on the Growth of HER2-Positive Breast Cancer Cells;Cells;2022-12-16